Colorectal Cancer Screening: Why Taking the Test Isn't the Finish Line, and What the Next Step Decides

11 October 2026
MIT
Colorectal Cancer Screening: Why Taking the Test Isn't the Finish Line, and What the Next Step Decides

Colorectal cancer screening is testing done in people who feel perfectly well, starting at age 45, to find polyps and remove them before they turn into cancer, or to catch a tumour while it is still small. But it is not one test. It is a chain: an invitation, a test, a colonoscopy if the result is positive, and a repeat on schedule. Drop any link and the benefit goes with it.


This article asks more than "which test is best?" It asks the question most advice skips: where does the chain usually break? The answer, as the evidence shows, is rarely at the machine or in the lab.


🔎 What is colorectal cancer screening, and why is it unlike other tests?


The US Centers for Disease Control and Prevention (CDC) defines it in one line: "A screening test is used to look for a disease when a person doesn't have symptoms." That definition is half of this article. Screening is not for people in pain. It is for people who feel fine.


The other half is what makes this cancer unusual. According to the CDC, colorectal cancer "almost always develops from abnormal growths in the colon or rectum, called polyps," and screening tests "can find polyps so they can be removed before they turn into cancer." In other words, screening here does not just detect disease early. It can prevent it outright.


Polyps are common and slow. Cleveland Clinic states that they affect about 20% of adults overall and about 40% of those over 50, and that many are harmless. The same source estimates that the risk of a random, average-size polyp becoming cancerous is about 8% over 10 years and 24% over 20 years. These are estimates from a single patient-education source, but the direction is clear: the window is measured in years, not weeks.


So the first conclusion is that this disease gives you time. The real question is what happens during that time.


🧩 Link one: the invitation that never becomes a test


In 2022 the first large randomized trial of screening colonoscopy was published, known as NordICC. As summarized by the US National Cancer Institute (NCI PDQ), data were reported for 84,585 participants aged 55 to 64 in Poland, Norway and Sweden: 28,220 were invited to colonoscopy and 56,365 received usual care.


At a median of 10 years, the risk of colorectal cancer was 0.98% in the invited group versus 1.20% in the usual-care group (risk ratio 0.82). Death from colorectal cancer was 0.28% versus 0.31%, a difference that did not reach statistical significance.


Many read that as "colonoscopy doesn't save lives." But the most important number in the trial is none of those. It is this: of the people invited, only 42% actually had the colonoscopy. The trial did not measure colonoscopy. It measured an invitation to colonoscopy. When the investigators estimated what would have happened had everyone invited been screened, the risk ratio for cancer became 0.69 and for cancer death 0.50. Those are modelled estimates, not direct results, and we report them as such.


Fairness cuts the other way too. The absolute difference in cancer risk was about 0.22 percentage points, or roughly 22 fewer cases per 10,000 people invited over ten years (our arithmetic, from the two published figures). That is real, but it is not a miracle. We explained the gap between relative and absolute risk in our article on statins and muscle aches. The NCI summary also lists the trial's own caveats, including that 29% of the endoscopists had an adenoma detection rate below the recommended minimum, and that follow-up may still be too short to show the full effect.


The lesson is not that colonoscopy is weak, and not that it is magic. The lesson is that a test nobody takes protects nobody, however accurate it looks on paper.


🧪 Link two: a stool test is not the end of the road


Colonoscopy is not the only option. The US Preventive Services Task Force (USPSTF) lists several acceptable strategies for average-risk adults, shown here as it gives them:


Fecal immunochemical test (FIT): every year.


Stool DNA-FIT: every 1 to 3 years.


CT colonography: every 5 years.


Flexible sigmoidoscopy: every 5 years, or every 10 years with an annual FIT.


Colonoscopy: every 10 years.


FIT is simple: a home sample that checks for tiny amounts of blood that cannot be seen, and, according to the NCI, it typically requires no dietary restrictions. That is why many programmes rely on it, including the service offered in Saudi Arabia.


This is also where many people fall out of the chain. A FIT does not diagnose cancer and does not remove a polyp. The CDC says that when a stool test, sigmoidoscopy or CT colonography comes back positive or abnormal, a colonoscopy is needed "to complete the screening process." Note the word: complete. A positive stool test without a colonoscopy is not a lower-quality screening. It is an unfinished one.


What does not finishing cost? The NCI reported on an Italian study (Zorzi and colleagues, in the journal Gut) from a regional screening programme in Veneto. Of 111,423 people with a positive FIT, 88,013 had the follow-up colonoscopy and 23,410 did not, which is about 21% (calculated from the published numbers). Those who did not were about twice as likely to die of colorectal cancer over a 10-year period. The study is observational, so people who skipped follow-up may differ in other ways, and fewer than 1% in either group died of the disease. Still, the direction justifies the sentence the NCI quoted from Dr. Douglas Corley: "cancer screening is really a process, not a single step."


The same logic applies to the new blood tests. The NCI notes that the Shield test is approved for average-risk adults aged 45 and older, but adds that blood-based tests "have not yet been incorporated into clinical guidelines for first-line colorectal cancer screening." An easier sample does not remove the next link.


📅 Link three: why did the colorectal cancer screening age move from 50 to 45?


For years the familiar number was 50. On 18 May 2021 the USPSTF issued its current recommendation: screening from 50 to 75 with an A grade, from 45 to 49 with a B grade, and selectively offered from 76 to 85 with a C grade. It applies explicitly to "asymptomatic adults 45 years or older who are at average risk of colorectal cancer."


The reason is that the age map shifted. The same document states that incidence in adults aged 40 to 49 has increased by almost 15%, and that an estimated 10.5% of new cases occur in people younger than 50. The World Health Organization, in a fact sheet dated February 2026, says the disease "predominantly affects individuals aged 50 and above," with "a rising burden among adults 30–50 years old in some settings."


Two notes for honesty. First, a B grade reflects less certainty than an A grade: the evidence for ages 45 to 49 is weaker than for older adults, not equal to it. Second, we checked the status of the recommendation on the day this article was written. The 2021 statement is the one currently published, and colorectal screening did not appear on the Task Force's list of recommendations in progress. If that changes, your doctor is the one to tell you.


People at higher risk do not wait for 45 at all. The CDC says screening may need to start earlier or happen more often for those with inflammatory bowel disease such as Crohn's disease or ulcerative colitis, a personal or family history of colorectal cancer or polyps, or a genetic syndrome such as Lynch syndrome.


🇸🇦 Link four: in Saudi Arabia the service exists, and the question goes unasked


The local picture deserves a careful reading, because it contains two statements that sound contradictory and are both true.


The first comes from the Saudi Ministry of Health: early screening is available at primary healthcare centres and hospitals for people aged 45 to 75 with no symptoms and no family history, using a FIT that is repeated yearly if negative and leads to a full colonoscopy if positive. Appointments can be booked through the Sehhaty app or a family medicine clinic.


The second comes from a 2026 review in the Saudi Medical Journal (Aljabri and Alharbi): the Kingdom "lacks a national systematic CRC screening program," and uptake is still below 10%. There is no contradiction. The service is there for those who ask, but no organized invitation reaches everyone who turns 45. The first link in the chain, the invitation, is left to you.


Nor is the disease rare locally. Citing the 2022 cancer registry, the review reports that it is the most common cancer among Saudi men and the third among Saudi women, with 2,535 cases representing 13.2% of newly diagnosed malignancies, and a median age at diagnosis of 60 for men and 59 for women. On how many are diagnosed late, we will not give you a single number, because the review itself cites figures that range from 29% to more than half. What can be said honestly is that the share is large and the exact figure is unsettled.


So why don't people come forward? A nationwide cross-sectional study (Alamer and colleagues, 2025, 573 participants aged over 40) gave two answers that sit side by side.


The first answer: 49.9% believed that having no symptoms means there is no need for screening. Set that beside the CDC definition at the top of this article: screening is defined as being for people without symptoms. About half the sample was using the entry condition for screening as the reason to skip it. We described a similar trap in our article on dysphagia and the missing cough.


The second answer: only 21.7% said a physician had ever recommended screening to them, while 84.5% said they would be screened if a physician recommended it. The gap between those two numbers is not fear and not cost. It is one sentence that was never said in the clinic.


The study's limits belong next to its numbers. It was a self-administered online survey using snowball sampling, which its authors say may favour more health-literate and digitally connected people, and 62.1% of participants came from the Central region. It does not give a national prevalence, and it records what people said about themselves, not what they did. We use it for one question only: which belief is common, and where does the invitation stall?


The practical conclusion is simple. If you are between 45 and 75 and nobody has asked you, ask.


🚩 When is what you need not "screening" at all?


Everything above concerns people with no complaints. If symptoms appear, you have left the screening pathway and entered the diagnostic one, and you should not wait for your yearly slot. The WHO says colorectal cancer "often has no or mild symptoms in the early stages," so the following call for a doctor's visit, not a home kit:


  • Blood in the stool, bright red or dark and tar-like. Mayo Clinic advises seeing a healthcare professional if you notice bleeding "even once or twice."
  • A lasting change in bowel habits: diarrhoea, constipation, or a change in stool shape.
  • Abdominal cramps, pain or bloating that won't go away.
  • A feeling that the bowel doesn't empty all the way.
  • Losing weight without trying, or persistent fatigue.
  • Iron deficiency anaemia with no clear cause.


These symptoms have many other causes, most of them benign, as the Ministry of Health points out. But deciding that they are benign is not your call to make. And remember that a negative FIT does not explain an existing symptom: the test was designed for people who have none.


⚖️ Who should be careful, and what should you ask your doctor?


Screening is not free of cost. The NCI notes that colonoscopy requires a thorough cleansing of the entire colon beforehand, usually involves sedation, and carries a small risk of tearing or perforation of the lining of the colon. In NordICC, fifteen participants had major bleeding after polyp removal, with no perforations or screening-related deaths within 30 days. CT colonography involves a small amount of radiation and may miss small polyps.


That is why the decision needs a conversation with your doctor in specific situations: if you are over 75, where the recommendation becomes selective and depends on overall health and prior screening; if you take blood thinners or have heart or lung disease that makes sedation riskier; and if you have a family history or inflammatory bowel disease, because the average-risk schedule does not fit you. The Ministry of Health also notes that FIT should be deferred in situations such as bleeding haemorrhoids and menstruation.


This article is educational and does not replace a consultation with your doctor, who decides which test suits you and when.


🥗 What about food? What we cannot promise you


We are a bakery, and you might expect a paragraph here saying our bread protects your colon. We won't write it, because it isn't true.


What health authorities say about diet is broader than any product. The WHO lists among the risk factors diets high in processed and red meat and low in fruits and vegetables, along with physical inactivity, overweight and obesity, tobacco and alcohol. The Saudi Ministry of Health lists low-fibre, high-fat diets, diabetes and obesity. Mayo Clinic describes the typical Western diet as low in fibre and high in sugar, fat and calories, and adds, candidly, that research on diet in this area has had mixed results.


One note concerns our own readers in particular. Someone following a low-carb pattern can drift, without noticing, toward a plate heavy in processed meat and light on vegetables and fibre. That is not a flaw in cutting sugar and refined starch. It is a flaw in how it is carried out. A good low-carb plate is full of leafy vegetables, seeds and nuts, with processed meat as the exception, not the rule.


Only in that frame do we mention our products. Bakery 8 almond-flour bread, our keto granola with nuts and seeds, and our crackers are ways to cut sugar and refined flour without giving up bread. They do not prevent a polyp, they do not find one, and they do not replace an appointment at a primary healthcare centre. In the WHO's words, it is screening that "has been shown to reduce both incidence and mortality." Not a loaf.


❓ Frequently asked questions about colorectal cancer screening


When should I start colorectal cancer screening?


For people at average risk, meaning no symptoms and no family history, screening starts at age 45 and continues to 75, according to the US Preventive Services Task Force and the Saudi Ministry of Health. People with a family history, inflammatory bowel disease or a genetic syndrome may need to start earlier and repeat more often, on a schedule set by their doctor.


Does a FIT stool test replace a colonoscopy?


It can, as long as the result is negative and the test is repeated every year. But it neither diagnoses cancer nor removes polyps, so a positive result makes colonoscopy necessary to complete the screening. In a large Italian study, about one in five people with a positive FIT skipped the colonoscopy and were about twice as likely to die of the disease.


I have no symptoms. Do I still need colorectal cancer screening?


Yes. Screening is defined as testing for people without symptoms. Polyps and many early cancers cause no symptoms at all, and the WHO says the disease often has no or mild symptoms in its early stages. Waiting for a symptom means waiting for a later stage. If you are between 45 and 75, ask your doctor.


How often is screening repeated if the result is normal?


It depends on the test: FIT every year, colonoscopy every 10 years for people at average risk, and CT colonography or flexible sigmoidoscopy every 5 years. One normal result is not a permanent certificate, because polyps form over time. If polyps were found and removed, your doctor will shorten the interval based on their number and type.


Where can I get screened in Saudi Arabia?


The Ministry of Health states that screening is available at primary healthcare centres and hospitals for people aged 45 to 75, and that appointments can be booked through the Sehhaty app or at a family medicine or chronic disease clinic. The first test is a FIT, and a positive result is referred for a full colonoscopy.


🌿 The takeaway: a screening that wasn't completed didn't happen


Colorectal cancer is one of the few cancers that gives you years of warning and a real chance of prevention. But that chance does not live in a device or a sample. It lives in a chain: being invited or asking, taking the test, following through with colonoscopy if needed, and coming back on schedule. The big trials did not expose weak tests so much as the cost of missing links.


At Bakery 8 (مخبز ثمانية) in Riyadh, Saudi Arabia, we bake for people who want less sugar and refined flour without losing the pleasure of bread, and we know our role ends at the table. If you have turned 45, the most important thing you can do this week is not in our store. It is in the Sehhaty app. After that, you are welcome at getbakery8.com.


References


  1. US Preventive Services Task Force. Colorectal Cancer: Screening — Final Recommendation Statement. 18 May 2021 (recommendation status checked 11 October 2026).
  2. Centers for Disease Control and Prevention. Screening for Colorectal Cancer. Reviewed 17 June 2026.
  3. National Cancer Institute. Screening Tests to Detect Colorectal Cancer and Polyps. Reviewed 29 October 2024.
  4. National Cancer Institute. Colorectal Cancer Screening (PDQ®) — Health Professional Version (summary of the NordICC trial, Bretthauer et al. 2022).
  5. National Cancer Institute, Cancer Currents. Follow-Up Colonoscopy after Positive FIT Test. 5 May 2022 (reporting Zorzi M, et al., Gut).
  6. World Health Organization. Colorectal cancer — Fact sheet. 13 February 2026.
  7. Cleveland Clinic. Colon Polyps: Different Types & Cancer Risk. Last updated 25 September 2023.
  8. Mayo Clinic. Colon cancer — Symptoms and causes.
  9. Saudi Ministry of Health. Colorectal Cancer Awareness (Awareness Platform); and Ministry news, "Colorectal cancer screening service available at primary healthcare centres," 8 March 2021.
  10. Aljabri AA, Alharbi AG. Colorectal Cancer Screening in Saudi Arabia: Current Challenges and Future Directions. Saudi Medical Journal. 2026;47(1):10–20. doi:10.15537/smj.2026.47.1.20250597
  11. Alamer IA, Altuwaijri RA, Alfraih SF, Alotaibi BS, Alqahtani MA, Alqasim SA, Bin Abdulrahman KA. Assessing Adherence and Identifying Barriers to Colorectal Cancer Screening in the Adult General Populations of Saudi Arabia: A Nationwide Cross-Sectional Study. Int J Environ Res Public Health. 2025;22(9):1386. doi:10.3390/ijerph22091386


Related keywords: colorectal cancer screening, colon cancer screening age 45, FIT stool test, colonoscopy, colon polyps, colon cancer symptoms, colorectal cancer screening in Saudi Arabia, Sehhaty app.